Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
PhD research shows: ‘repeating vaccination promotes whooping cough resistance’ Repeating vaccination promotes whooping cough resistance. This is evidenced by the PhD research conducted by Pauline Versteegen. She researched post-vaccination immunity to whooping cough in age groups from 7 to 70 years. On Tuesday 28 May, she was awarded her doctoral degree at Utrecht University.
Approach needed to tackle polluting activities to protect drinking water sources In the Netherlands, we derive our drinking water from two sources: groundwater and river water. In many areas, the quality of this water is not adequate. The measures taken to improve the quality have yet to yield significant direct effects.
Many serious cases of whooping cough among newborn babies in the Netherlands The number of newborn babies in the Netherlands who are seriously ill due to whooping cough has been increasingly rapidly in recent weeks. About 110 confirmed cases of whooping cough are now being diagnosed every week among children in the Netherlands, including nearly 20 infants.
Respiratory infections now in season More and more people are coughing and sneezing, although it is not an epidemic at this point. The season in which respiratory infections circulate in the Netherlands has now started. There are various viruses that can cause respiratory infections.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
Flu vaccine campaign about to start In October, many people will receive a new invitation to get the flu vaccine. The flu vaccine protects people who, because of their age or medical condition, are more likely to become ill or seriously ill from flu.
RIVM creates risk assessment toolbox to assess local groundwater quality RIVM has developed the Groundwater Risk Assessment Toolbox. This risk assessment toolbox allows local authorities to quickly determine whether a specific groundwater application is safe. They can then take action if necessary.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.